219 related articles for article (PubMed ID: 27183704)
1. Topical hydrocortisone 17-butyrate 21-propionate in the treatment of inflammatory skin diseases: pharmacological data, clinical efficacy, safety and calculation of the therapeutic index.
Fölster-Holst R; Abeck D; Torrelo A
Pharmazie; 2016 Mar; 71(3):115-21. PubMed ID: 27183704
[TBL] [Abstract][Full Text] [Related]
2. Topical mometasone. A review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders.
Prakash A; Benfield P
Drugs; 1998 Jan; 55(1):145-63. PubMed ID: 9463794
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacological study on hydrocortisone 17-butyrate 21-propionate (author's transl)].
Otomo S; Higuchi S; Nakaike S; Takeshita K; Tanaka M; Gotoh Y; Osada Y; Tsuchida K; Inoue K; Kyogoku K; Tarumoto Y; Sasajima M; Ohzeki M
Nihon Yakurigaku Zasshi; 1981 Dec; 78(6):647-58. PubMed ID: 7333567
[TBL] [Abstract][Full Text] [Related]
4. Prednicarbate activity and benefit/risk ratio in relation to other topical glucocorticoids.
Schäfer-Korting M; Korting HC; Kerscher MJ; Lenhard S
Clin Pharmacol Ther; 1993 Oct; 54(4):448-56. PubMed ID: 8222488
[TBL] [Abstract][Full Text] [Related]
5. In vivo assessment of the atrophogenic potency of mometasone furoate, a newly developed chlorinated potent topical glucocorticoid as compared to other topical glucocorticoids old and new.
Kerscher MJ; Hart H; Korting HC; Stalleicken D
Int J Clin Pharmacol Ther; 1995 Apr; 33(4):187-9. PubMed ID: 7620686
[TBL] [Abstract][Full Text] [Related]
6. A comparison of fluticasone propionate ointment, 0.005%, and hydrocortisone-17-butyrate ointment, 0.1%, in the treatment of psoriasis.
Nurnberger FG
Cutis; 1996 Feb; 57(2 Suppl):39-44. PubMed ID: 8646868
[TBL] [Abstract][Full Text] [Related]
7. Methylprednisolone aceponate in eczema and other inflammatory skin disorders -- a clinical update.
Ruzicka T
Int J Clin Pract; 2006 Jan; 60(1):85-92. PubMed ID: 16409433
[TBL] [Abstract][Full Text] [Related]
8. Comparative toxicity study of hydrocortisone 17-butyrate 21-propionate (HBP) ointment and other topical corticosteroids in rats.
Kimura M; Tarumoto Y; Nakane S; Otomo S
Drugs Exp Clin Res; 1986; 12(8):643-52. PubMed ID: 3757761
[TBL] [Abstract][Full Text] [Related]
9. Topical fluticasone propionate: intervention and maintenance treatment options of atopic dermatitis based on a high therapeutic index.
Korting HC; Schöllmann C
J Eur Acad Dermatol Venereol; 2012 Feb; 26(2):133-40. PubMed ID: 21977914
[TBL] [Abstract][Full Text] [Related]
10. Comparison of mometasone furoate 0.1% cream and hydrocortisone 1.0% cream in the treatment of childhood atopic dermatitis.
Vernon HJ; Lane AT; Weston W
J Am Acad Dermatol; 1991 Apr; 24(4):603-7. PubMed ID: 2033138
[TBL] [Abstract][Full Text] [Related]
11. Hydrocortisone 17-butyrate: a new topical corticosteroid preliminary report.
Brogden RN; Pinder RM; Sawyer PR; Speight TM; Avery GS
Drugs; 1976; 12(4):249-57. PubMed ID: 786608
[TBL] [Abstract][Full Text] [Related]
12. New and established topical corticosteroids in dermatology: clinical pharmacology and therapeutic use.
Brazzini B; Pimpinelli N
Am J Clin Dermatol; 2002; 3(1):47-58. PubMed ID: 11817968
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, multicenter trial comparing fluticasone propionate cream, 0.05%, and hydrocortisone-17-butyrate cream, 0.1%, applied twice daily for 4 weeks in the treatment of psoriasis.
James M
Cutis; 2001 Apr; 67(4 Suppl):2-9. PubMed ID: 11338723
[TBL] [Abstract][Full Text] [Related]
14. Activity of topically applied methylprednisolone aceponate in relation to other topical glucocorticosteroids in healthy volunteers.
Kecskés A; Jahn P; Wendt H; Kleine-Kuhlmann R; Lange L
Arzneimittelforschung; 1993 Feb; 43(2):144-7. PubMed ID: 8457237
[TBL] [Abstract][Full Text] [Related]
15. A comparison of once-daily application of mometasone furoate 0.1% cream compared with twice-daily hydrocortisone valerate 0.2% cream in pediatric atopic dermatitis patients who failed to respond to hydrocortisone: mometasone furoate study group.
Lebwohl M
Int J Dermatol; 1999 Aug; 38(8):604-6. PubMed ID: 10487451
[No Abstract] [Full Text] [Related]
16. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
[TBL] [Abstract][Full Text] [Related]
17. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R;
Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of hydrocortisone buteprate 0.1% cream in patients with atopic dermatitis.
Sears HW; Bailer JW; Yeadon A
Clin Ther; 1997; 19(4):710-9. PubMed ID: 9377615
[TBL] [Abstract][Full Text] [Related]
19. Hydrocortisone acetate alone or combined with mupirocin for atopic dermatitis in infants under two years of age - a randomized double blind pilot trial.
Canpolat F; Erkoçoğlu M; Tezer H; Kocabaş CN; Kandi B
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1989-93. PubMed ID: 23242727
[TBL] [Abstract][Full Text] [Related]
20. Hydrocortisone butyrate 0.1% cream (proprietary lipid rich cream vehicle) does not significantly suppress hypothalamic-pituitary-adrenal axis and is effective in pediatric patients 3 months and older with extensive atopic dermatitis.
Abramovits W; Oquendo M
Skinmed; 2010; 8(3):150-4. PubMed ID: 21137620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
